Weaver Samantha R, Torres Haydee M, Arnold Katherine M, Zars Elizabeth L, Peralta-Herrera Eduardo, Taylor Earnest L, Yu Kanglun, Marron Fernandez de Velasco Ezequiel, Wickman Kevin, McGee-Lawrence Meghan E, Bradley Elizabeth W, Westendorf Jennifer J
Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN 55905, United States.
Altis Biosystems, Durham, NC 27709, United States.
JBMR Plus. 2024 Aug 4;8(10):ziae108. doi: 10.1093/jbmrpl/ziae108. eCollection 2024 Oct.
Osteoporosis and other metabolic bone diseases are prevalent in the aging population. While bone has the capacity to regenerate throughout life, bone formation rates decline with age and contribute to reduced bone density and strength. Identifying mechanisms and pathways that increase bone accrual in adults could prevent fractures and accelerate healing. G protein-gated inwardly rectifying K (GIRK) channels are key effectors of G protein-coupled receptor signaling. was recently shown to regulate endochondral ossification. Here, we demonstrate that deletion of increases bone mass after 18 weeks of age. Male 24-week-old mice have greater trabecular bone mineral density and bone volume fraction than wildtype (WT) mice. Osteoblast activity is moderately increased in 24-week-old mice compared to WT mice. In vitro, bone marrow stromal cells (BMSCs) are more proliferative than WT BMSCs. Calvarial osteoblasts and BMSCs from mice are also more osteogenic than WT cells, with altered expression of genes that regulate the wingless-related integration site (Wnt) family. Wnt inhibition via Dickkopf-1 (Dkk1) or β-catenin inhibition via XAV939 prevents enhanced mineralization, but not proliferation, in BMSCs and slows these processes in WT cells. Finally, selective ablation of from cells expressing Cre recombinase from the 2.3 kb-Col1a1 promoter, including osteoblasts and osteocytes, is sufficient to increase bone mass and bone strength in male mice at 24 weeks of age. Taken together, these data demonstrate that regulates progenitor cell proliferation, osteoblast differentiation, and bone mass accrual in adult male mice.
骨质疏松症和其他代谢性骨病在老年人群中普遍存在。虽然骨骼在一生中都有再生能力,但骨形成率会随着年龄增长而下降,导致骨密度和强度降低。确定能够增加成年人骨量的机制和途径可以预防骨折并加速愈合。G蛋白门控内向整流钾(GIRK)通道是G蛋白偶联受体信号传导的关键效应器。最近的研究表明它能调节软骨内成骨。在此,我们证明在18周龄后缺失该通道会增加骨量。24周龄的雄性该通道缺失小鼠比野生型(WT)小鼠具有更高的小梁骨矿物质密度和骨体积分数。与WT小鼠相比,24周龄的该通道缺失小鼠的成骨细胞活性适度增加。在体外,该通道缺失的骨髓间充质干细胞(BMSC)比WT BMSC更具增殖性。该通道缺失小鼠的颅骨成骨细胞和BMSC也比WT细胞更具成骨性,且与调节无翅相关整合位点(Wnt)家族的基因表达改变有关。通过Dickkopf-1(Dkk1)抑制Wnt或通过XAV939抑制β-连环蛋白可阻止该通道缺失BMSC中矿化增强,但不影响增殖,并减缓WT细胞中的这些过程。最后,从2.3 kb - Col1a1启动子表达Cre重组酶的细胞(包括成骨细胞和骨细胞)中选择性切除该通道,足以增加24周龄雄性小鼠的骨量和骨强度。综上所述,这些数据表明该通道调节成年雄性小鼠祖细胞增殖、成骨细胞分化和骨量积累。